Micronoma Patents – Insights & Stats (Updated 2023)

Micronoma has a total of 26 patents globally, out of which no patent have been granted. Of these 26 patents, more than 88% patents are active. Europe, Canada and Japan is where Micronoma has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Micronoma.

Micronoma was founded in 2019. Micronoma is a company that’s use liquid biopsy technology for detecting and predicting cancer early on. They do this by examining microbial signals with high accuracy, helping identify cancer at its initial stages.

Do read about some of the most popular patents of Micronoma which have been covered by us in this article and also you can find Micronoma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Micronoma patent portfolio.

How many patents does Micronoma have?

Micronoma has a total of 26 patents globally. These patents belong to 8 unique patent families. Out of 26 patents, 23 patents are active.

How Many Patents did Micronoma File Every Year?

Micronoma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMicronoma Applications FiledMicronoma Patents Granted
20235
20223
202118

How many Micronoma patents are Alive/Dead?

Worldwide Patents

Micronoma Patent Portfolio

How Many Patents did Micronoma File in Different Countries?

Micronoma Worldwide Patent Filing

Countries in which Micronoma Filed Patents

CountryPatent
Europe3
Canada3
China3
Israel2
Mexico2
Brazil2
United States Of America1
Singapore1
India1

Where are Research Centers of Micronoma Patents Located?

The Research Centers of Micronoma Patents is the United States of America.

List of Micronoma patents

Micronoma PatentsTitle
US20230420134A1Cancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis
EP4268232A1Taxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
EP4244374A1Cancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis
EP4244856A1Systems And Methods To Improve Therapeutic Outcomes
CN117203705ATaxonomy-Independent Cancer Diagnosis And Classification Using Microbial Nucleic Acids And Somatic Mutations
CN117083679ASystems And Methods For Improving Treatment Outcomes
CN116917495ACancer Diagnosis And Classification By Non-Human Metagenome Pathway Analysis
WO2023173034A3Disease Classifiers From Targeted Microbial Amplicon Sequencing
WO2023215765A1Systems And Methods For Enriching Cell-Free Microbial Nucleic Acid Molecules
WO2023059922A3Metaepigenomics-Based Disease Diagnostics
WO2023034618A1Methods Of Identifying Cancer-Associated Microbial Biomarkers
WO2023003917A1Methods Of Disease Diagnostics Utilizing Microbial Extracellular Vesicle (Mev) Analytes
CA3202888A1Taxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
CA3199032A1Cancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis
CA3198341A1Systems And Methods To Improve Therapeutic Outcomes
MX2023007515ADiagnosis And Classification Of Cancer Independent Of Taxonomy Using Microbial Nucleic Acids And Somatic Mutations
BR112023012453A2Taxonomy And Classification-Independent Cancer Diagnosis Using Microbial Nucleic Acids And Somatic Mutations
BR112023009406A2Cancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis
MX2023005749ADiagnosis And Classification Of Cancer Through The Analysis Of Non-Human Metagenomic Pathways
IL303849ATaxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
IL302908ACancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis
IN202317048446ATaxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
SG11202304861TATaxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
WO2022140616A1Taxonomy-Independent Cancer Diagnostics And Classification Using Microbial Nucleic Acids And Somatic Mutations
WO2022103975A1Systems And Methods To Improve Therapeutic Outcomes
WO2022104278A1Cancer Diagnosis And Classification By Non-Human Metagenomic Pathway Analysis

What are Micronoma key innovation segments?

What Technologies are Covered by Micronoma?

The chart below distributes patents filed by Micronoma in different countries on the basis of the technology protected in patents. It also represents the markets where Micronoma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Micronoma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Micronoma?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.